Cassava Sciences | PTIE - Assets

Stock Price
1.61
Daily Change
-0.05 -3.01%
Monthly
-12.02%
Yearly
2.55%
Q2 Forecast
1.58

Cassava Sciences reported $118.35M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Amgen USD 90.59B 445M Dec/2025
Biogen USD 29.44B 232M Dec/2025
Cara Therapeutics USD 39.02M 4.73M Sep/2025
Cassava Sciences USD 118.35M 11.38M Dec/2025
Eisai JPY 1.49T 48.22B Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Geron USD 570.54M 3.16M Dec/2025
J&J USD 200.89B 1.68B Mar/2026
Merck USD 129.55B 12.02B Sep/2025
Novartis USD 110.95B 3.66B Dec/2025
Novavax USD 1.18B 3.38M Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025